Barclays’s iShares Biotechnology ETF IBB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $49.4M | Sell |
|
|||||
|
2025
Q1 | $92.2M | Buy |
|
|||||
|
2024
Q4 | $89.7M | Buy |
|
|||||
|
2024
Q3 | $52M | Buy |
|
|||||
|
2024
Q2 | $5.64M | Buy |
|
|||||
|
2024
Q1 | $266K | Sell |
|
|||||
|
2023
Q4 | $461K | Sell |
|
|||||
|
2023
Q3 | $2.42M | Sell |
|
|||||
|
2023
Q2 | $17M | Sell |
|
|||||
|
2023
Q1 | $19.6M | Buy |
|
|||||
|
2022
Q4 | $346K | Sell |
|
|||||
|
2022
Q3 | $45.8M | Buy |
|
|||||
|
2022
Q2 | $15.1M | Sell |
|
|||||
|
2022
Q1 | $40.1M | Sell |
|
|||||
|
2021
Q4 | $48.2M | Sell |
|
|||||
|
2021
Q3 | $263M | Buy |
|
|||||
|
2021
Q2 | $228M | Buy |
|
|||||
|
2021
Q1 | $182M | Sell |
|
|||||
|
2020
Q4 | $206M | Sell |
|
|||||
|
2020
Q3 | $279M | Sell |
|
|||||
|
2020
Q2 | $356M | Sell |
|
|||||
|
2020
Q1 | $330M | Sell |
|
|||||
|
2019
Q4 | $376M | Sell |
|
|||||
|
2019
Q3 | $315M | Buy |
|
|||||
|
2019
Q2 | $17.2M | Sell |
|
|||||
|
2019
Q1 | $19.8M | Buy |
|
|||||
|
2018
Q4 | $4.89M | Buy |
|
|||||
|
2018
Q3 | $2.41M | Sell |
|
|||||
|
2018
Q2 | $3.74M | Sell |
|
|||||
|
2018
Q1 | $24.1M | Buy |
|
|||||
|
2017
Q4 | $15.2M | Buy |
|
|||||
|
2017
Q3 | $13.7M | Sell |
|
|||||
|
2017
Q2 | $40.5M | Sell |
|
|||||
|
2017
Q1 | $94.4M | Buy |
|
|||||
|
2016
Q4 | $48.3M | Buy |
|
|||||
|
2016
Q3 | $49.3M | Buy |
|
|||||
|
2016
Q2 | $36.4M | Buy |
|
|||||
|
2016
Q1 | $32.2M | Buy |
|
|||||
|
2015
Q4 | $12.4M | Sell |
|
|||||
|
2015
Q3 | $65.2M | Buy |
|
|||||
|
2015
Q2 | $942K | Buy |
|
|||||
|
2015
Q1 | $21K | Sell |
|
|||||
|
2014
Q4 | $90.4M | Sell |
|
|||||
|
2014
Q3 | $216M | Buy |
|
|||||
|
2014
Q2 | $190M | Sell |
|
|||||
|
2014
Q1 | $244M | Buy |
|
|||||
|
2013
Q4 | $140M | Sell |
|
|||||
|
2013
Q3 | $146M | Buy |
|
|||||
|
2013
Q2 | $116M | Buy |
|